Progressive Pseudorheumatoid Dysplasia resolved by whole exome sequencing: a novel mutation in WISP3 and review of the literature
Abstract Background Progressive pseudorheumatoid dysplasia (PPRD) is a rare autosomal-recessive, non-inflammatory arthropathy, shown to be caused by mutations in the WNT1-inducible signaling pathway protein 3 (WISP3) gene. Although several hundred cases were reported worldwide, the diagnosis remains...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-03-01
|
Series: | BMC Medical Genetics |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12881-019-0787-x |
_version_ | 1818320964187848704 |
---|---|
author | Ben Pode-Shakked Asaf Vivante Ortal Barel Shai Padeh Dina Marek-Yagel Alvit Veber Shachar Abudi Aviva Eliyahu Irit Tirosh Shiri Shpilman Shirlee Shril Friedhelm Hildebrandt Mordechai Shohat Yair Anikster |
author_facet | Ben Pode-Shakked Asaf Vivante Ortal Barel Shai Padeh Dina Marek-Yagel Alvit Veber Shachar Abudi Aviva Eliyahu Irit Tirosh Shiri Shpilman Shirlee Shril Friedhelm Hildebrandt Mordechai Shohat Yair Anikster |
author_sort | Ben Pode-Shakked |
collection | DOAJ |
description | Abstract Background Progressive pseudorheumatoid dysplasia (PPRD) is a rare autosomal-recessive, non-inflammatory arthropathy, shown to be caused by mutations in the WNT1-inducible signaling pathway protein 3 (WISP3) gene. Although several hundred cases were reported worldwide, the diagnosis remains challenging. Subsequently, the syndrome is often unrecognized and misdiagnosed (for instance, as Juvenile Idiopathic Arthritis), leading to unnecessary procedures and treatments. The objective of the current study was to identify the molecular basis in a family with PPRD and describe their phenotype and course of illness. Patients and methods We present here a multiply affected consanguineous family of Iraqi-Jewish descent with PPRD. The proband, a 6.5 years old girl, presented with bilateral symmetric bony enlargements of the 1st interphalangeal joints of the hands, without signs of synovitis. Molecular analysis of the family was pursued using Whole Exome Sequencing (WES) and homozygosity mapping. Results WES analysis brought to the identification of a novel homozygous missense mutation (c.257G > T, p.C86F) in the WISP3 gene. Following this diagnosis, an additional 53 years old affected family member was found to harbor the mutation. Two other individuals in the family were reported to have had similar involvement however both had died of unrelated causes. Conclusion The reported family underscores the importance of recognition of this unique skeletal dysplasia by clinicians, and especially by pediatric rheumatologists and orthopedic surgeons. |
first_indexed | 2024-12-13T10:33:22Z |
format | Article |
id | doaj.art-21ee6b5247cf41b39363d1574af2d8da |
institution | Directory Open Access Journal |
issn | 1471-2350 |
language | English |
last_indexed | 2024-12-13T10:33:22Z |
publishDate | 2019-03-01 |
publisher | BMC |
record_format | Article |
series | BMC Medical Genetics |
spelling | doaj.art-21ee6b5247cf41b39363d1574af2d8da2022-12-21T23:50:47ZengBMCBMC Medical Genetics1471-23502019-03-012011610.1186/s12881-019-0787-xProgressive Pseudorheumatoid Dysplasia resolved by whole exome sequencing: a novel mutation in WISP3 and review of the literatureBen Pode-Shakked0Asaf Vivante1Ortal Barel2Shai Padeh3Dina Marek-Yagel4Alvit Veber5Shachar Abudi6Aviva Eliyahu7Irit Tirosh8Shiri Shpilman9Shirlee Shril10Friedhelm Hildebrandt11Mordechai Shohat12Yair Anikster13Metabolic Disease Unit, Edmond and Lily Safra Children’s Hospital, Sheba Medical CenterDivision of Nephrology, Department of Medicine, Boston Children’s Hospital, Harvard Medical SchoolSheba Cancer Research Center, Sheba Medical CenterPediatric Rheumatology Unit and Department of Pediatrics, Edmond and Lily Safra Children’s Hospital, Sheba Medical CenterMetabolic Disease Unit, Edmond and Lily Safra Children’s Hospital, Sheba Medical CenterMetabolic Disease Unit, Edmond and Lily Safra Children’s Hospital, Sheba Medical CenterMetabolic Disease Unit, Edmond and Lily Safra Children’s Hospital, Sheba Medical CenterMetabolic Disease Unit, Edmond and Lily Safra Children’s Hospital, Sheba Medical CenterPediatric Rheumatology Unit and Department of Pediatrics, Edmond and Lily Safra Children’s Hospital, Sheba Medical CenterPediatric Rheumatology Unit and Department of Pediatrics, Edmond and Lily Safra Children’s Hospital, Sheba Medical CenterDivision of Nephrology, Department of Medicine, Boston Children’s Hospital, Harvard Medical SchoolDivision of Nephrology, Department of Medicine, Boston Children’s Hospital, Harvard Medical SchoolSheba Cancer Research Center, Sheba Medical CenterMetabolic Disease Unit, Edmond and Lily Safra Children’s Hospital, Sheba Medical CenterAbstract Background Progressive pseudorheumatoid dysplasia (PPRD) is a rare autosomal-recessive, non-inflammatory arthropathy, shown to be caused by mutations in the WNT1-inducible signaling pathway protein 3 (WISP3) gene. Although several hundred cases were reported worldwide, the diagnosis remains challenging. Subsequently, the syndrome is often unrecognized and misdiagnosed (for instance, as Juvenile Idiopathic Arthritis), leading to unnecessary procedures and treatments. The objective of the current study was to identify the molecular basis in a family with PPRD and describe their phenotype and course of illness. Patients and methods We present here a multiply affected consanguineous family of Iraqi-Jewish descent with PPRD. The proband, a 6.5 years old girl, presented with bilateral symmetric bony enlargements of the 1st interphalangeal joints of the hands, without signs of synovitis. Molecular analysis of the family was pursued using Whole Exome Sequencing (WES) and homozygosity mapping. Results WES analysis brought to the identification of a novel homozygous missense mutation (c.257G > T, p.C86F) in the WISP3 gene. Following this diagnosis, an additional 53 years old affected family member was found to harbor the mutation. Two other individuals in the family were reported to have had similar involvement however both had died of unrelated causes. Conclusion The reported family underscores the importance of recognition of this unique skeletal dysplasia by clinicians, and especially by pediatric rheumatologists and orthopedic surgeons.http://link.springer.com/article/10.1186/s12881-019-0787-xWISP3CCN6Progressive pseudorheumatoid dysplasiaPPRDPseudorheumatoid arthritis of childhood |
spellingShingle | Ben Pode-Shakked Asaf Vivante Ortal Barel Shai Padeh Dina Marek-Yagel Alvit Veber Shachar Abudi Aviva Eliyahu Irit Tirosh Shiri Shpilman Shirlee Shril Friedhelm Hildebrandt Mordechai Shohat Yair Anikster Progressive Pseudorheumatoid Dysplasia resolved by whole exome sequencing: a novel mutation in WISP3 and review of the literature BMC Medical Genetics WISP3 CCN6 Progressive pseudorheumatoid dysplasia PPRD Pseudorheumatoid arthritis of childhood |
title | Progressive Pseudorheumatoid Dysplasia resolved by whole exome sequencing: a novel mutation in WISP3 and review of the literature |
title_full | Progressive Pseudorheumatoid Dysplasia resolved by whole exome sequencing: a novel mutation in WISP3 and review of the literature |
title_fullStr | Progressive Pseudorheumatoid Dysplasia resolved by whole exome sequencing: a novel mutation in WISP3 and review of the literature |
title_full_unstemmed | Progressive Pseudorheumatoid Dysplasia resolved by whole exome sequencing: a novel mutation in WISP3 and review of the literature |
title_short | Progressive Pseudorheumatoid Dysplasia resolved by whole exome sequencing: a novel mutation in WISP3 and review of the literature |
title_sort | progressive pseudorheumatoid dysplasia resolved by whole exome sequencing a novel mutation in wisp3 and review of the literature |
topic | WISP3 CCN6 Progressive pseudorheumatoid dysplasia PPRD Pseudorheumatoid arthritis of childhood |
url | http://link.springer.com/article/10.1186/s12881-019-0787-x |
work_keys_str_mv | AT benpodeshakked progressivepseudorheumatoiddysplasiaresolvedbywholeexomesequencinganovelmutationinwisp3andreviewoftheliterature AT asafvivante progressivepseudorheumatoiddysplasiaresolvedbywholeexomesequencinganovelmutationinwisp3andreviewoftheliterature AT ortalbarel progressivepseudorheumatoiddysplasiaresolvedbywholeexomesequencinganovelmutationinwisp3andreviewoftheliterature AT shaipadeh progressivepseudorheumatoiddysplasiaresolvedbywholeexomesequencinganovelmutationinwisp3andreviewoftheliterature AT dinamarekyagel progressivepseudorheumatoiddysplasiaresolvedbywholeexomesequencinganovelmutationinwisp3andreviewoftheliterature AT alvitveber progressivepseudorheumatoiddysplasiaresolvedbywholeexomesequencinganovelmutationinwisp3andreviewoftheliterature AT shacharabudi progressivepseudorheumatoiddysplasiaresolvedbywholeexomesequencinganovelmutationinwisp3andreviewoftheliterature AT avivaeliyahu progressivepseudorheumatoiddysplasiaresolvedbywholeexomesequencinganovelmutationinwisp3andreviewoftheliterature AT irittirosh progressivepseudorheumatoiddysplasiaresolvedbywholeexomesequencinganovelmutationinwisp3andreviewoftheliterature AT shirishpilman progressivepseudorheumatoiddysplasiaresolvedbywholeexomesequencinganovelmutationinwisp3andreviewoftheliterature AT shirleeshril progressivepseudorheumatoiddysplasiaresolvedbywholeexomesequencinganovelmutationinwisp3andreviewoftheliterature AT friedhelmhildebrandt progressivepseudorheumatoiddysplasiaresolvedbywholeexomesequencinganovelmutationinwisp3andreviewoftheliterature AT mordechaishohat progressivepseudorheumatoiddysplasiaresolvedbywholeexomesequencinganovelmutationinwisp3andreviewoftheliterature AT yairanikster progressivepseudorheumatoiddysplasiaresolvedbywholeexomesequencinganovelmutationinwisp3andreviewoftheliterature |